1224PDAnalysis of response and survival in patients (pts) with ipilimumab (ipi)-refractory melanoma treated with pembrolizumab (pembro) in KEYNOTE-002
Daud, A., Puzanov, I., Dummer, R., Schadendorf, D., Hamid, O., Robert, C., Hodi, F.S., Schachter, J., Sosman, J., Pavlick, A.C., Gonzalez, R., Blank, C.U., Cranmer, L., O’Day, S.J., Salama, A.K., MargVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx377.011
Date:
September, 2017
File:
PDF, 52 KB
english, 2017